{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T10:12:04Z","timestamp":1789380724081,"version":"build-2803163510"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,28]]},"DOI":"10.7759\/cureus.49598","type":"journal-article","created":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T03:48:50Z","timestamp":1701229730000},"source":"Crossref","is-referenced-by-count":1,"title":["Overlap of Primary Membranous Nephropathy, IgA Nephropathy, and Diabetic Nephropathy: A Case Report"],"prefix":"10.7759","author":[{"given":"Abdullah H","family":"Alghamdi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.01868","article-title":"Nephrotic syndrome: oedema formation and its treatment with diuretics","volume":"9","author":"Gupta S","year":"2019","unstructured":"Gupta S, Pepper RJ, Ashman N, Walsh SB. Nephrotic syndrome: oedema formation and its treatment with diuretics. Front Physiol. 2019, 9:1868. 10.3389\/fphys.2018.01868","journal-title":"Front Physiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04160413","article-title":"Glomerular diseases: membranous nephropathy--a modern view","volume":"9","author":"Ponticelli C","year":"2014","unstructured":"Ponticelli C, Glassock RJ. Glomerular diseases: membranous nephropathy--a modern view. Clin J Am Soc Nephrol. 2014, 9:609-16. 10.2215\/CJN.04160413","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2019.07.014","article-title":"The anti-PLA2R antibody in membranous nephropathy: what we know and what remains a decade after its discovery","volume":"96","author":"van de Logt AE","year":"2019","unstructured":"van de Logt AE, Fresquet M, Wetzels JF, Brenchley P. The anti-PLA2R antibody in membranous nephropathy: what we know and what remains a decade after its discovery. Kidney Int. 2019, 96:1292-302. 10.1016\/j.kint.2019.07.014","journal-title":"Kidney Int"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/PAP.0000000000000134","article-title":"Pathophysiology of IgA nephropathy","volume":"24","author":"Al Hussain T","year":"2017","unstructured":"Al Hussain T, Hussein MH, Al Mana H, Akhtar M. Pathophysiology of IgA nephropathy. Adv Anat Pathol. 2017, 24:56-62. 10.1097\/PAP.0000000000000134","journal-title":"Adv Anat Pathol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/MS9.0000000000000855","article-title":"Immunoglobulin A nephropathy in remission: a case report","volume":"85","author":"Mahat A","year":"2023","unstructured":"Mahat A, Lageju N, Neupane D, Mishra U, Koirala S. Immunoglobulin A nephropathy in remission: a case report. Ann Med Surg. 2023, 85:3137-9. 10.1097\/MS9.0000000000000855","journal-title":"Ann Med Surg"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/med\/9780199592548.003.0149_update_001","article-title":"The patient with diabetes mellitus","author":"Gnudi L","year":"2018","unstructured":"Gnudi L, Gentile G, Ruggenenti P. The patient with diabetes mellitus. Oxford Textbook of Clinical Nephrology. Turner, Neil N. (ed): Oxford University Press, Oxford, United Kingdom; 2018. 1199:247. 10.1093\/med\/9780199592548.003.0149_update_001"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2337\/dc21-1944","article-title":"Finerenone in patients with chronic kidney disease and type 2 diabetes according to baseline HbA1c and insulin use: an analysis from the FIDELIO-DKD study","volume":"45","author":"Rossing P","year":"2022","unstructured":"Rossing P, Burgess E, Agarwal R, et al.. Finerenone in patients with chronic kidney disease and type 2 diabetes according to baseline HbA1c and insulin use: an analysis from the FIDELIO-DKD study. Diabetes Care. 2022, 45:888-97. 10.2337\/dc21-1944","journal-title":"Diabetes Care"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.846323","article-title":"Concurrent IgA nephropathy and membranous nephropathy, is it an overlap syndrome?","volume":"13","author":"He JW","year":"2022","unstructured":"He JW, Cui DF, Zhou XJ, et al.. Concurrent IgA nephropathy and membranous nephropathy, is it an overlap syndrome?. Front Immunol. 2022, 13:846323. 10.3389\/fimmu.2022.846323","journal-title":"Front Immunol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/17.1.140","article-title":"Development of IgA nephropathy 14 years after diagnosis of membranous nephropathy","volume":"17","author":"Miyazaki K","year":"2002","unstructured":"Miyazaki K, Miyazaki M, Tsurutani H, et al.. Development of IgA nephropathy 14 years after diagnosis of membranous nephropathy. Nephrol Dial Transplant. 2002, 17:140-3. 10.1093\/ndt\/17.1.140","journal-title":"Nephrol Dial Transplant"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2015.07.006","article-title":"AJKD atlas of renal pathology: membranous nephropathy","volume":"66","author":"Fogo AB","year":"2015","unstructured":"Fogo AB, Lusco MA, Najafian B, Alpers CE. AJKD atlas of renal pathology: membranous nephropathy. Am J Kidney Dis. 2015, 66:15-7. 10.1053\/j.ajkd.2015.07.006","journal-title":"Am J Kidney Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016040449","article-title":"Rituximab for severe membranous nephropathy: a 6-month trial with extended follow-up","volume":"28","author":"Dahan K","year":"2017","unstructured":"Dahan K, Debiec H, Plaisier E, et al.. Rituximab for severe membranous nephropathy: a 6-month trial with extended follow-up. J Am Soc Nephrol. 2017, 28:348-58. 10.1681\/ASN.2016040449","journal-title":"J Am Soc Nephrol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2009080861","article-title":"Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy","volume":"21","author":"Polanco N","year":"2010","unstructured":"Polanco N, Guti\u00e9rrez E, Covars\u00ed A, et al.. Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy. J Am Soc Nephrol. 2010, 21:697-704. 10.1681\/ASN.2009080861","journal-title":"J Am Soc Nephrol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4103\/1319-2442.256863","article-title":"Primary membranous nephropathy with concomitant IgA nephropathy","volume":"30","author":"Khorsan R","year":"2019","unstructured":"Khorsan R, Hanna RM, Ameen K, et al.. Primary membranous nephropathy with concomitant IgA nephropathy. Saudi J Kidney Dis Transpl. 2019, 30:531-6. 10.4103\/1319-2442.256863","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21175954","article-title":"Recurrent glomerulonephritis after renal transplantation: the clinical problem","volume":"21","author":"Infante B","year":"2020","unstructured":"Infante B, Rossini M, Leo S, et al.. Recurrent glomerulonephritis after renal transplantation: the clinical problem. Int J Mol Sci. 2020, 21:5954. 10.3390\/ijms21175954","journal-title":"Int J Mol Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1159\/000364954","article-title":"Long-term outcome of IgA nephropathy patients with recurrent macroscopic hematuria","volume":"40","author":"Le W","year":"2014","unstructured":"Le W, Liang S, Chen H, et al.. Long-term outcome of IgA nephropathy patients with recurrent macroscopic hematuria. Am J Nephrol. 2014, 40:43-50. 10.1159\/000364954","journal-title":"Am J Nephrol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1206793","article-title":"IgA nephropathy","volume":"368","author":"Wyatt RJ","year":"2013","unstructured":"Wyatt RJ, Julian BA. IgA nephropathy. N Engl J Med. 2013, 368:2402-14. 10.1056\/NEJMra1206793","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-019-0403-4","article-title":"Diabetic nephropathy: recent advances in pathophysiology and challenges in dietary management","volume":"11","author":"Sulaiman MK","year":"2019","unstructured":"Sulaiman MK. Diabetic nephropathy: recent advances in pathophysiology and challenges in dietary management. Diabetol Metab Syndr. 2019, 11:7. 10.1186\/s13098-019-0403-4","journal-title":"Diabetol Metab Syndr"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-023-03206-1","article-title":"Monthly mini-dose rituximab for primary anti-PLA2R-positive membranous nephropathy: a personalized approach","volume":"24","author":"Wang S","year":"2023","unstructured":"Wang S, Deng Z, Wang Y, Bao W, Zhou S, Cui Z, Zheng D. Monthly mini-dose rituximab for primary anti-PLA2R-positive membranous nephropathy: a personalized approach. BMC Nephrol. 2023, 24:146. 10.1186\/s12882-023-03206-1","journal-title":"BMC Nephrol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1191\/0961203305lu2138oa","article-title":"Anti-B cell therapy (rituximab) in the treatment of autoimmune diseases","volume":"14","author":"Chambers SA","year":"2005","unstructured":"Chambers SA, Isenberg D. Anti-B cell therapy (rituximab) in the treatment of autoimmune diseases. Lupus. 2005, 14:210-4. 10.1191\/0961203305lu2138oa","journal-title":"Lupus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/204678-overlap-of-primary-membranous-nephropathy-iga-nephropathy-and-diabetic-nephropathy-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:07:55Z","timestamp":1707509275000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/204678-overlap-of-primary-membranous-nephropathy-iga-nephropathy-and-diabetic-nephropathy-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,28]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.49598","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,28]]}}}